Daniel Mediati

Dr. Daniel Mediati is a Chancellor's Research Fellow and Lecturer at the University of Technology Sydney (UTS), leading the Molecular Systems Biology Lab within the Australian Institute for Microbiology and Infection. He holds adjunct roles at UNSW Sydney. His research focuses on bacterial interactions with hosts and environments to uncover mechanisms for therapeutic and biotechnological applications, with a particular emphasis on antimicrobial resistance and RNA regulatory networks. He has received prestigious awards including the 2024 ASM Jim Pittard Early Career Award and the 2023 EMBL Corporate Partnerships Award.

Mediati holds a BSc (Hons I) in Biotechnology and a PhD in Molecular Microbiology from UTS, alongside a GradCert in Higher Education. His work has been highlighted in Forbes Magazine (2022) and featured in news releases from the Australian Academy of Sciences and ABC Radio (2023). He currently coordinates the 91132-Molecular Biology subject in UTS's School of Life Sciences and actively seeks motivated Honours and PhD students.

He serves on the editorial boards of Access Microbiology and eLife, and as a communications ambassador for the Australian Society for Microbiology (NSW-ACT chapter). His funded research includes a UTS fellowship (2024–2028) and an NHMRC Ideas grant (2024–2026) with UNSW's Prof. Jai Tree.

Key research outputs include studies on silver nanoparticle resistance in pathogens, genetic requirements for E. coli proliferation in urinary tract infections, and sRNA regulatory networks in Staphylococcus aureus. His work bridges microbiology and RNA technologies, with implications for combating antibiotic resistance and developing novel therapies.